gemcitabine has been researched along with purine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batzler, A; Fridley, BL; Jenkins, GD; Ji, Y; Li, F; Li, L; Matimba, A; Wang, L; Weinshilboum, RM | 1 |
| Beauregard, J; Collins, L; Dostie, S; Guindon, Y; Labbé, MO; Lefebvre, CA; Maharsy, W; Nemer, M; Prévost, M | 1 |
2 other study(ies) available for gemcitabine and purine
| Article | Year |
|---|---|
Gene set analysis of purine and pyrimidine antimetabolites cancer therapies.
Topics: Antimetabolites; Antineoplastic Agents; Area Under Curve; Cell Line, Tumor; Deoxycytidine; Gemcitabine; Genes, Neoplasm; Humans; Neoplasms; Phenotype; Purines; Pyrimidines; Reproducibility of Results; Thioguanine | 2011 |
Identification of a C3'-nitrile nucleoside analogue inhibitor of pancreatic cancer cell line growth.
Topics: Amides; Antineoplastic Agents; Apoptosis; Benzylamines; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gemcitabine; Glycosylation; Humans; Mutation; Nitriles; Pancreatic Neoplasms; Phosphoric Acids; Proto-Oncogene Proteins p21(ras); Purines; Structure-Activity Relationship | 2020 |